AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

GlobeStar Therapeutics Corporation

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0 - $0
Market Cap
124.11K
AVG Volume
85
Trailing/Forward PE
-0.04/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
02K4K6K22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
24 Q30
24 Q20
24 Q10
23 Q40
23 Q30
23 Q20
23 Q10
22 Q40
22 Q34.82K
22 Q24.82K
Net Income (USD) · TTM
-10M-7.5M-5M-2.5M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
24 Q3-888K
24 Q2-1.97M
24 Q1-1.95M
23 Q4-1.95M
23 Q3-1.91M
23 Q2-782.31K
23 Q1-1.32M
22 Q4-1.49M
22 Q3-5.44M
22 Q2-9.8M
Operating Income (USD) · TTM
-10M-7.5M-5M-2.5M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
24 Q3-805K
24 Q2-1.89M
24 Q1-1.87M
23 Q4-1.86M
23 Q3-1.88M
23 Q2-733.84K
23 Q1-1.25M
22 Q4-1.26M
22 Q3-5.05M
22 Q2-9.39M
EBITDA (USD) · TTM
-10M-7.5M-5M-2.5M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
24 Q3-587.6K
24 Q2-581.23K
24 Q1-413.17K
23 Q4-256.93K
23 Q3-287.62K
23 Q2-441.02K
23 Q1-1.1M
22 Q4-1.42M
22 Q3-5.31M
22 Q2-9.65M
Cash Flows (USD) · TTM
-800K-600K-400K-200K022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
24 Q3-148.28K
24 Q2-168.06K
24 Q1-209.42K
23 Q4-205.76K
23 Q3-171.71K
23 Q2-179.5K
23 Q1-236.6K
22 Q4-327K
22 Q3-709.11K
22 Q2-799.56K
EPS (USD) · TTM
-0.02-0.01-0.01-0022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
24 Q3-0
24 Q2-0
24 Q1-0
23 Q4-0
23 Q3-0
23 Q2-0
23 Q1-0
22 Q4-0
22 Q3-0.01
22 Q2-0.02
Expenses (USD) · TTM
-2.5M02.5M5M7.5M10MSG&ACapex22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
24 Q3804.59K
24 Q21.89M
24 Q11.86M
23 Q41.86M
23 Q31.88M
23 Q2733.76K
23 Q11.25M
22 Q41.27M
22 Q35.05M
22 Q29.39M
Shares Outstanding (USD) · TTM
-10M-7.5M-5M-2.5M0Buybacks (Repurchases)Stock-Based Compensation22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
GSTC Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
24 Q3-143.77K
24 Q2-1.28M
24 Q1-1.28M
23 Q4-1.27M
23 Q3-1.18M
23 Q2-68.44K
23 Q1-527K
22 Q4-509.19K
22 Q3-4.41M
22 Q2-8.61M
Employee Count
0123420212022
GSTC Employee Count by quarter
PeriodEmployee Count
20223
20213
Free Cash Flow Yield
-15000%-10000%-5000%0%med -122.65%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
GSTC Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-122.65%
Sep 26-122.65%
Aug 26-12265.21%
Aug 26-122.65%
Aug 26-122.65%
Aug 26-122.65%
Jul 26-122.65%
Jul 26-122.65%
Jul 26-122.65%
Jul 26-122.65%
Jul 26-122.65%
Jun 26-122.65%
Jun 26-12265.21%
Jun 26-12265.21%
Jun 26-122.65%
May 26-122.65%
May 26-122.65%
May 26-122.65%
May 26-122.65%
May 26-122.65%
Apr 26-122.65%
Apr 26-12265.21%
Apr 26-122.65%
Apr 26-122.65%
Mar 26-122.65%
Mar 26-122.65%
Mar 26-122.65%
Mar 26-122.65%
Feb 26-122.65%
Feb 26-122.65%
Feb 26-122.65%
Feb 26-122.65%
Jan 26-122.65%
Jan 26-122.65%
Jan 26-12265.21%
Jan 26-122.65%
Jan 26-122.65%
Dec 25-122.65%
Dec 25-12265.21%
Dec 25-122.65%
Dec 25-122.65%
Nov 25-12265.21%
Nov 25-122.65%
Nov 25-122.65%
Nov 25-122.65%
Oct 25-122.65%
Oct 25-122.65%
Oct 25-122.65%
Oct 25-122.65%
Oct 25-122.65%
Sep 25-122.65%
Sep 25-122.65%
Sep 25-122.65%
Sep 25-122.65%
Aug 25-122.65%
Aug 25-122.65%
Aug 25-122.65%
Aug 25-122.65%
Aug 25-122.65%
Jul 25-122.65%
Jul 25-122.65%
Jul 25-122.65%
Jul 25-122.65%
Jun 25-122.65%
Jun 25-122.65%
Jun 25-122.65%
Jun 25-12265.21%
May 25-122.65%
May 25-122.65%
May 25-122.65%
May 25-122.65%
May 25-12265.21%
Apr 25-61.33%
Apr 25-61.33%
Apr 25-61.33%
Apr 25-61.33%
Mar 25-61.33%
Mar 25-40.88%
Mar 25-40.88%
Mar 25-40.88%
Feb 25-40.88%
Feb 25-40.88%
Feb 25-40.88%
Feb 25-49.06%
Jan 25-40.88%
Jan 25-40.88%
Jan 25-40.88%
Jan 25-35.04%
Jan 25-30.66%
Dec 24-40.88%
Dec 24-40.88%
Dec 24-40.88%
Dec 24-35.04%
Nov 24-30.66%
Nov 24-40.88%
Nov 24-40.88%
Nov 24-30.66%
Nov 24-30.66%
Oct 24-35.04%
Oct 24-30.66%
Price to Sales
020000400006000080000med 1038.63May 20Aug 20Dec 20Feb 22Jun 22Sep 22Jan 23
GSTC Price to Sales by quarter
PeriodPrice to Sales
Jan 231585.8
Dec 221757.6
Dec 221546.16
Dec 221929.39
Dec 222828.01
Dec 221612.23
Nov 221665.09
Nov 22700.4
Nov 22634.32
Nov 22515.39
Oct 22502.17
Oct 22330.38
Oct 22396.45
Oct 22449.31
Sep 22488.96
Sep 22422.88
Sep 22409.67
Sep 22462.53
Sep 22422.88
Aug 22488.96
Aug 22448.36
Aug 22386.08
Aug 22435.9
Jul 22498.17
Jul 22672.53
Jul 22485.72
Jul 22423.45
Jul 22560.44
Jun 22485.72
Jun 22485.72
Jun 22460.81
Jun 22460.81
May 22511.15
May 22546.81
May 22368.5
May 22546.81
Apr 22653.79
Apr 22867.76
Apr 22927.2
Apr 22909.37
Apr 22891.53
Mar 22950.97
Mar 22986.63
Mar 22790.49
Mar 22832.1
Feb 22843.99
Feb 22927.2
Feb 221044.64
Feb 221000.18
Jan 221044.64
Jan 221333.58
Jan 221666.97
Jan 221922.58
Jan 2154198.39
Jan 2161941.02
Jan 2132906.17
Dec 2029228.42
Dec 2024389.28
Dec 2025163.54
Dec 2022453.62
Dec 2026131.37
Nov 2014356.65
Nov 2012476.61
Nov 2012818.44
Nov 2012647.53
Oct 2014356.65
Oct 2012134.79
Oct 2012134.79
Oct 2011280.23
Oct 2010425.66
Sep 2011109.31
Sep 208716.54
Sep 209742.01
Sep 2011023.86
Aug 2013673
Aug 206494.68
Aug 204101.9
Aug 204443.73
Jul 203589.16
Jul 202905.51
Jul 204956.46
Jul 202284.98
Jul 202284.98
Jun 202284.98
Jun 201869.53
Jun 201246.35
Jun 201038.63
May 201038.63
May 20830.9
May 20830.9
May 201038.63
May 20867.22
Apr 201005.48
Apr 201173.06
Apr 201089.27
Apr 201256.85
Mar 201214.95
Mar 20670.32
Mar 20670.32
Mar 20837.9
EV/EBITDA
02468med 1.86Feb 15Apr 15May 15Jul 15Sep 15Nov 15Jan 16
GSTC EV/EBITDA by quarter
PeriodEV/EBITDA
Jan 162.18
Dec 152.16
Dec 152.18
Dec 152.27
Dec 152.66
Dec 152.72
Nov 152.66
Nov 152.98
Nov 153.78
Nov 154.59
Oct 154.47
Oct 153.55
Oct 154.47
Oct 156.5
Oct 157.06
Sep 153.55
Sep 153.31
Sep 154.14
Sep 154.14
Aug 153.43
Aug 153.43
Aug 152.08
Aug 152.28
Jul 152.28
Jul 152.53
Jul 153.21
Jul 151.54
Jul 151.64
Jun 150.93
Jun 150.94
Jun 150.94
Jun 150.94
May 150.94
May 150.94
May 150.94
May 151.07
May 151.07
Apr 151.07
Apr 151.08
Apr 151.07
Apr 151.08
Mar 151.08
Mar 151.08
Mar 151.08
Mar 151.07
Feb 151.08
Feb 151.08
Feb 151.12
Feb 151.11
Jan 151.11
Jan 151.11
Jan 151.11
Price to Book
0102030med 0.72Feb 14Feb 16Oct 16Dec 16Jan 17Feb 17Apr 17
GSTC Price to Book by quarter
PeriodPrice to Book
Apr 170.37
Mar 170.37
Mar 170.37
Mar 170.37
Mar 170.44
Mar 170.44
Feb 170.44
Feb 170.44
Feb 170.37
Feb 170.59
Jan 170.59
Jan 170.55
Jan 170.67
Jan 170.78
Dec 160.81
Dec 161.04
Dec 160.67
Dec 161.12
Dec 161.85
Nov 161.83
Nov 161.85
Nov 161.85
Nov 162.34
Oct 161.63
Oct 161.18
Oct 162.77
Oct 161.92
Sep 160.89
Sep 160.55
Sep 160.59
Feb 1618.07
Feb 1614.3
Feb 1615.6
Jan 1613
Jan 1618.57
Jan 1622.88
Feb 140
Jan 140
Jan 140
Jan 140
GlobeStar Therapeutics Corporation
GSTC
Stockpicker

Video analysis: GSTC

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.